Xarelto tablets comprise of an active ingredient called rivaroxaban. This is used primarily for deep vein thrombosis prevention that often leads to pulmonary embolism in patients who are recovering from hip or knee replacement surgery. Some of the most common adverse reactions here include bleeding complications, itching, fainting as well as muscle spasm.

2. What is Xarelto
Xarelto (rivaroxaban) is a prescription
blood thinner medicine intended to
reduce blood clotting. It comes in tablet
form. The U.S. Food and Drug
Administration approved the drug for
numerous purposes.
The FDA approved Xarelto in July 2011
to reduce the risk of deep vein
thrombosis, or DVT, and pulmonary
embolism, or PE, following knee
replacement or hip replacement surgery.
The FDA also approved Xarelto in
November 2011 to reduce the risk of
stroke in people who have a type of
abnormal heart rhythm called non-valvular
atrial fibrillation.

3. Xarelto Rivaroxaban is a new
oral anticoagulant that was
introduced in the year 2011 as
a competitor to Pradaxa and as
a substitute to warfarin. It is
prescribed for treating various
chronic medical issues and
other blood clot injuries.
Unlike the majority of the
blood thinners that have the
risks of inner bleeding.
Xarelto is alleged to have
higher degree of risks than
what was specified in the
warnings provided by the
manufacturers for the entire
medical community and the
customers.

4. A part of the Xarelto Medication Guide reads, “Xarelto can cause
internal bleeding, which can be serious, and rarely may lead to death.”
Accordingly, the warnings instruct patients to call their doctors
immediately if any of the following signs of serious bleeding occur:
• Unexpected bleeding or bleeding that lasts a long time, such as:
- Nosebleeds that happen often
- Unusual bleeding from gums
- Menstrual bleeding that is heavier than normal or vaginal bleeding
• Bleeding that is severe or that you cannot control
• Red, pink, or brown urine
• Bright red or black stools (looks like tar)
• Cough up blood or blood clots
• Vomit blood or your vomit looks like “coffee grounds”
• Headaches, feeling dizzy or weak
• Pain, swelling, or new drainage at wound sites

5. No doubt all blood thinners carry
the risk of internal bleeding, but
Xarelto seems to pose a higher
risk than indicated by the
manufacturers provided for both
the consumers as well as the
medical community as a whole.
Though the drug makers
highlighted the fact that it needs
less frequent monitoring, they
withheld information about lack
of effective reversal agent in order
to stop bleeding.
There are various legal firms who
are reviewing the plaintiff claims,
as well as potential Xarelto Class
Action Lawsuits.

6. Xarelto lawsuits have been filed against Janssen in numerous states
stemming from Xarelto side effects, which include uncontrollable
internal bleeding.
Victims and their surviving family members who file Xarelto lawsuits
seek compensatory and punitive damages based on the Xarelto side
effects and on the manufacturer’s alleged failure to properly warn
about them.
The FDA released a warning that patients who suddenly stop taking
Xarelto can be at increased risk for developing blood clots. Xarelto’s
predecessor, Pradaxa, has already led to a number of lawsuits filed
against its manufacturer because of complications such as excessive
bleeding and death.
Lawsuits claim the drug's makers misrepresented the safety and
effectiveness of the drug. Those currently involved in litigation allege
the companies continued to sell Xarelto even when they knew it was
dangerous.